lly glp 1 drug Stock Surges on Breakthrough Oral GLP-1 Trial Results Eli Lilly stock swings after
Description
National Institute of Diabetes and Digestive and Kidney Diseases (2022)
We look forward to working with Ascendis to explore the potential of the TransCon technology platform to reduce the dosing frequency of GLP-1 receptor agonists and other treatments for cardiometabolic diseases.
prices for GLP-1 drugs range from $570 to over $1,400 monthly based on the drug and insurance
doi:10.2337/diabetes.50.8.1720 235
